The Survivorship Passport for childhood cancer survivors: improvements and experience within several European PanCare projects

BACKGROUND/PURPOSE: As the population of childhood cancer survivors (CCS) continues to grow, personalized long-term follow-up (LTFU) care has become essential for ensuring optimal quality of life. The Survivorship Passport (SurPass) was developed to support efficient delivery of high-quality LTFU care, with the provision of treatment summaries and personalized follow-up recommendations. Updates to SurPass, from version v1.1 to v2.0, were made possible through two complementary European-funded projects: PanCareFollowUp and PanCareSurPass. METHODS: Within PanCareFollowUp, SurPass was updated with new variables and algorithms based on International Guideline Harmonization Group/PanCare guidelines (v1.2) and tested in one clinic. During PanCareSurPass, the platform was updated to v2.0, featuring certification as Medical Device (MD) and interoperability with Electronic Health Information Systems, and deployed across clinical sites in six European countries. RESULTS: The current SurPass v2.0 includes 242 variables and 47 algorithms for generation of the Standardized Care Plan. It is certified as MD and supports both manual and semi-automatic data entry through the adoption of Health Level Seven International Fast Healthcare Interoperability Resources (HL7-FHIR). The preliminary experience with SurPass delivered to 207 CCS in Italy within the PanCareFollowUp is reported. CONCLUSION: Interoperability via HL7-FHIR and the MD certification of the SurPass allow its use in clinical practice, and a reduction in time needed to generate the document providing homogeneous and personalized LTFU care for European CCS. Cost of interoperability through HL7-FHIR is offset by savings due to time reduction for TS generation. Experience in one clinic document the satisfaction of survivors who shared the document with their family doctors. IMPLICATIONS FOR CANCER SURVIVORS: The Survivorship Passport (SurPass) provides childhood cancer survivors with a standardized, personalized summary of their cancer treatment and individualized follow-up recommendations based on international guidelines. Its implementation across multiple European countries demonstrates the feasibility of delivering consistent survivorship information that can support long-term follow-up, facilitate communication between survivors and healthcare providers, and promote informed engagement in survivorship care.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Survivorship
Published
2026-07-16
DOI
https://doi.org/10.1007/s11764-026-02078-2
Primary Topic
Childhood Cancer Survivors' Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Survivorship Passport for childhood cancer survivors: improvements and experience within several European PanCare projects

Monika Kapitančukė, G. Schreier, A Beccaria, María Teresa Tormo Alcañiz et al.
Journal of Cancer Survivorship
Childhood Cancer Survivors' Quality of Life
article

The Survivorship Passport for childhood cancer survivors: improvements and experience within several European PanCare projects

Monika Kapitančukė, G. Schreier, A Beccaria, María Teresa Tormo Alcañiz, Gerald Gredinger, Giacomo Cavalca, Giorgio Cangioli, Jelena Rascon, Giulia Stabile, Riccardo Haupt, Roberta Gazzarata, Edit Bárdi, Anke Neumann, Justas Trinkūnas, Davide Saraceno, Monica Muraca, Lisa Pelanconi, Anne Uyttebroeck, Ramona Tallone, Desiree Grabow, Francesca Bagnasco, Sara Oberti, Alessandra Berti, Tom Brié, Erik Vanden Meersch, Helena van der Pal, Ruth Ladenstein, Stefan Beyer, Brigitte Nicolas, Antonio Orduña Galán, Leontien Kremer, Kylie O’Brian, Anna-Liesa Filibert, Julia Balaguer Gull, Catherine Chronaki, Thokozani Reuben Ngidi, Rebecca Kalsbeek, Thorsten Langer
article en

Abstract

BACKGROUND/PURPOSE: As the population of childhood cancer survivors (CCS) continues to grow, personalized long-term follow-up (LTFU) care has become essential for ensuring optimal quality of life. The Survivorship Passport (SurPass) was developed to support efficient delivery of high-quality LTFU care, with the provision of treatment summaries and personalized follow-up recommendations. Updates to SurPass, from version v1.1 to v2.0, were made possible through two complementary European-funded projects: PanCareFollowUp and PanCareSurPass. METHODS: Within PanCareFollowUp, SurPass was updated with new variables and algorithms based on International Guideline Harmonization Group/PanCare guidelines (v1.2) and tested in one clinic. During PanCareSurPass, the platform was updated to v2.0, featuring certification as Medical Device (MD) and interoperability with Electronic Health Information Systems, and deployed across clinical sites in six European countries. RESULTS: The current SurPass v2.0 includes 242 variables and 47 algorithms for generation of the Standardized Care Plan. It is certified as MD and supports both manual and semi-automatic data entry through the adoption of Health Level Seven International Fast Healthcare Interoperability Resources (HL7-FHIR). The preliminary experience with SurPass delivered to 207 CCS in Italy within the PanCareFollowUp is reported. CONCLUSION: Interoperability via HL7-FHIR and the MD certification of the SurPass allow its use in clinical practice, and a reduction in time needed to generate the document providing homogeneous and personalized LTFU care for European CCS. Cost of interoperability through HL7-FHIR is offset by savings due to time reduction for TS generation. Experience in one clinic document the satisfaction of survivors who shared the document with their family doctors. IMPLICATIONS FOR CANCER SURVIVORS: The Survivorship Passport (SurPass) provides childhood cancer survivors with a standardized, personalized summary of their cancer treatment and individualized follow-up recommendations based on international guidelines. Its implementation across multiple European countries demonstrates the feasibility of delivering consistent survivorship information that can support long-term follow-up, facilitate communication between survivors and healthcare providers, and promote informed engagement in survivorship care.

Journal of Cancer Survivorship
Johannes Kepler University of Linz (AT), AIT Austrian Institute of Technology GmbH (AT), Vilnius Gediminas Technical University (LT), Vilnius University (LT), Johannes Gutenberg University Mainz (DE), Istituto Giannina Gaslini (IT), Graz University of Technology (AT), Pintail (Ireland) (IE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Health Level Seven International (BE), University Hospital Schleswig-Holstein (DE), Cineca (IT), Cancer Research Institute of the Slovak Academy of Sciences (SK), Gesundheit Österreich (AT), St Anna Children's Hospital (AT), Princess Máxima Center (NL), Consorzio Interuniversitario Nazionale per l'Informatica (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Vilnius University Hospital Santariskiu Klinikos (LT), Instituto de Investigación Sanitaria La Fe (ES), Medical University of Vienna (AT), University of Lübeck (DE), University of Bologna (IT), KU Leuven (BE)
Partnerships for the goals
Openalex Percentile: Top 6%
Childhood Cancer Survivors' Quality of Life
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.